John Marshall, MD, defined the focus for the scientific briefing portion of this year’s symposium: young people getting GI cancers at an alarming rate.
Honoring Individuals Who Have Made Transformative Strides in the Lives of Patients with Gastrointestinal Cancers
Learn about new Ruesch faculty led GI cancer research, the potential impact of new grants and patient community-building initiatives.
One of the most meaningful gifts you can give cancer patients and their families is hope.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
Ruesch Center Symposium Focuses on Early-Onset GI Cancer
December 5th, 2023
John Marshall, MD, director of the Ruesch Center, defined the focus for the scientific briefing portion of this year’s symposium: young people getting GI cancers at an alarming rate.…
FDA Approval of Fruquintinib Expands Later-Line Treatment Options in mCRC
December 5th, 2023
John L. Marshall, MD, sheds light on the significance of the FDA approval of fruquintinib for patients with heavily pretreated metastatic colorectal cancer and discusses the efficacy and safety data from the FRESCO and FRESCO-2 trials that supported the decision in this population.…
Luminary Awards Highlight Exemplary Work of Experts in GI Cancers
November 1st, 2023
The Luminary Awards in GI Cancers are designed to highlight the lifetime achievements of individuals who have dedicated their careers to expanding the knowledge of the GI cancer community.…
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver information on upcoming educational events, current clinical trials, and cutting-edge research and trends in the GI cancer field.
